Literature DB >> 3965624

Immunohistochemical diagnosis of olfactory neuroblastoma.

H S Choi, P J Anderson.   

Abstract

Olfactory neuroblastoma (OLF NB) is an uncommon neurogenic tumor arising in the nasal cavity. To identify the immunohistochemical reactivity of OLF NB, we examined specimens from ten patients for the presence of neuron-specific enolase (NSE), S-100 protein (S-100) and glial fibrillary acidic protein (GFAP). Formalin-fixed paraffin sections were treated with rabbit antisera using the peroxidase-antiperoxidase (PAP) and avidin-biotin immunofluorescence methods. Results were compared with those observed in four neuroblastomas (two central and two peripheral sites), 17 medulloblastomas, four pheochromocytomas and five paragangliomas. All OLF NB were positive for NSE and S-100. NSE was uniformly distributed throughout clusters of tumor cells within tumor nodules. The S-100 reactivity was distributed in neoplastic cell nuclei and long cytoplasmic processes of cells which interconnected to form a network at the periphery of tumor cell nests. GFAP was observed only in astrocyte-like cells in one tumor. Although the S-100-positive cells in OLF NB resembled S-100-positive sustentacular cells of paraganglioma and pheochromocytoma, the network pattern was distinctive in OLF NB. The immunodiagnostic pattern of OLF NB includes the following: (a) NSE present in irregular clusters of tumor cells, (b) S-100 present in peripheral cells which form a marginal network, (c) and GFAP rarely present.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965624     DOI: 10.1097/00005072-198501000-00002

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  10 in total

1.  Cushing's Syndrome: An Unusual Presentation of Olfactory Neuroblastoma.

Authors:  Lydia Josephs; Lamont Jones; Lawrence Marenette; Paul McKeever
Journal:  Skull Base       Date:  2008-01

2.  Retreatment of advanced esthesioneuroblastoma with high-activity I-125 endocurietherapy: a case report.

Authors:  P P Kumar; F P Ogren; R D McComb; E O Jones; G F McCaul
Journal:  J Natl Med Assoc       Date:  1991-08       Impact factor: 1.798

3.  Esthesioneuroblastoma: a nasal catecholamine-producing tumor of neural crest origin. Demonstration of tyrosine hydroxylase-immunoreactive tumor cells.

Authors:  H Takahashi; K Wakabayashi; F Ikuta; K Tanimura
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 4.  The biology and pathology of selected skull base tumors.

Authors:  L Barnes; S B Kapadia
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Type C retroviral expression in spontaneous feline olfactory neuroblastomas.

Authors:  M D Schrenzel; R J Higgins; S H Hinrichs; M O Smith; M Torten
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Intracranial olfactory neuroblastoma: evidence for olfactory epithelial origin.

Authors:  A K Banerjee; B S Sharma; R K Vashista; V K Kak
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

7.  Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).

Authors:  M E Carney; R C O'Reilly; B Sholevar; O I Buiakova; L D Lowry; W M Keane; F L Margolis; J L Rothstein
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

8.  Pigmented esthesioneuroblastoma showing dual differentiation following transplantation in nude mice. An immunohistochemical, electron microscopical, and cytogenetic analysis.

Authors:  A Llombart-Bosch; C Carda; A Peydro-Olaya; R Noguera; J Boix; A Pellin
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

9.  Esthesioneuroepithelioma: a tumor of true olfactory epithelium origin. An ultrastructural and immunohistochemical study.

Authors:  H Takahashi; S Ohara; M Yamada; F Ikuta; K Tanimura; Y Honda
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

10.  Gamma-enolase and glial fibrillary acidic protein in nervous system tumors. An immunohistochemical study using specific monoclonal antibodies.

Authors:  P Cras; J J Martin; J Gheuens
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.